✦ LIBER ✦

Differences in metastatic potential in HER2 positive and triple negative inflammatory breast cancer

✍ Scribed by Daniela Kolarevic; Zorica Tomasevic

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bevacizumab in HER2-negative non-metasta

✍ Neil Bennet 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 66 KB

Paclitaxel, carboplatin, and trastuzumab

✍ Andrew D. Seidman; Larry Norton 📂 Article 📅 2005 🏛 Current Science Inc. 🌐 English ⚖ 136 KB

Efficacy of ixabepilone in ER/PR/HER2-ne

✍ Edith A. Perez; Tejal Patel; Alvaro Moreno-Aspitia 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 214 KB

Pattern of metastatic spread in triple-n

✍ Rebecca Dent; Wedad M. Hanna; Maureen Trudeau; Ellen Rawlinson; Ping Sun; Steven 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 180 KB

Pertuzumab plus trastuzumab and docetaxe

✍ Jame Abraham 📂 Article 📅 2012 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 100 KB

High incidence of HER-2 positivity in in

✍ M Parton; M Dowsett; S Ashley; M Hills; F Lowe; I.E Smith 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 185 KB